Synapse - Works

Results (12936)

Prognostic impact of activating mutations of the NRAS/KRAS genes in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)

Meeting Abstract

Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Puga, R. D.; Paiva, R. D. A.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
Blood (2018)

Fulltext@MSK | Save

A novel prognostic model including cytogenetic and molecular data in patients with primary and post-essential thrombocythemia (ET)/polycythemia vera (PV) myelofibrosis (MF)

Meeting Abstract

Santos, F. P. S.; Getta, B.; Masarova, L.; Famulare, C.; Schulman, J.; Datoguia, T. S.; Goncalves, G. A. R.; Hamerschlak, N.; Kantarjian, H. M.; Levine, R. L.; more...
Blood (2018)

Fulltext@MSK | Save

RNA binding protein RBMX is required in acute myeloid leukemia by regulating the transcriptional activity of the heterochromatin protein HP1 alpha

Meeting Abstract

Prieto, C.; Nguyen, D.; Vu, L. P.; Perez, A.; Gourkanti, S.; Schurer, A.; Chou, T.; Chow, A.; Taggart, J.; Barlowe, T. S.; more...
Blood (2018)

Fulltext@MSK | Save

High throughput droplet single-cell genotyping of transcriptomes (GoT) reveals the cell identity dependency of the transcriptional output of somatic mutations

Meeting Abstract

Nam, A. S.; Kim, K. T.; Chaligne, R.; Izzo, F.; Ang, C.; Omans, N.; Pastore, A.; Taylor, J.; Alonso, A.; Tam, W.; more...
Blood (2018)

Fulltext@MSK | Save

Clinical responses and pharmacokinetics of MCARH171, a human-derived BCMA targeted CAR T cell therapy in relapsed/refractory multiple myeloma: Final results of a phase I clinical trial

Meeting Abstract

Mailankody, S.; Ghosh, A.; Staehr, M.; Purdon, T. J.; Roshal, M.; Halton, E.; Diamonte, C.; Pineda, J.; Anant, P.; Bernal, Y.; more...
Blood (2018)

Fulltext@MSK | Save

Dependency of spliceosomal mutant MDS on innate immune signaling

Meeting Abstract

Lee, S. C.; North, K.; Chen, C. C.; Kim, E.; Lu, S. X.; Ki, M.; Garippa, R.; Lowe, S. W.; Bradley, R. K.; Abdel-Wahab, O. I.
Blood (2018)

Fulltext@MSK | Save

Therapeutic targeting of an RNA splicing factor network for the treatment of myeloid neoplasms

Meeting Abstract

Lu, S. X.; Wang, E.; Pastore, A.; Xufeng, C.; Imig, J.; Lee, S. C.; Ghebrechristos, Y.; Yoshimi, A.; Bitner, L. E.; Ki, M.; more...
Blood (2018)

Fulltext@MSK | Save

Comprehensive single-cell RNA-sequencing mapping of primary acute myeloid leukemias and profiling of NPM1-mutated cells

Meeting Abstract

Lavallee, V. P.; Azizi, E.; Kiseliovas, V.; Masilionis, I.; Mazutis, L.; Levine, R. L.; Pe'er, D.
Blood (2018)

Fulltext@MSK | Save

MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone

Meeting Abstract

Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
Blood (2018)

Fulltext@MSK | Save

Epigenetic drug treatment induces presentation of new class of non-exonic cryptic neoantigens in acute myeloid leukemia cells

Meeting Abstract

Klatt, M. G.; Mun, S. S.; Socci, N. D.; Korontsvit, T.; Dao, T.; Scheinberg, D. A.
Blood (2018)

Fulltext@MSK | Save